Tuncer-Ertem, G. Et Al. 2015. Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir. KLIMIK JOURNAL , vol.28, no.2 , 92-94.

Tuncer-Ertem, G., Sayan, M., Hekimoglu, S., & Tulek, N., (2015). Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir. KLIMIK JOURNAL , vol.28, no.2, 92-94.

Tuncer-Ertem, Gunay Et Al. "Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir," KLIMIK JOURNAL , vol.28, no.2, 92-94, 2015

Tuncer-Ertem, Gunay Et Al. "Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir." KLIMIK JOURNAL , vol.28, no.2, pp.92-94, 2015

Tuncer-Ertem, G. Et Al. (2015) . "Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir." KLIMIK JOURNAL , vol.28, no.2, pp.92-94.

@article{article, author={Gunay Tuncer-Ertem Et Al. }, title={Cross Resistance to HCV NS3 Inhibitor Developing During Treatment With Peginterferon, Ribavirin and Telaprevir}, journal={KLIMIK JOURNAL}, year=2015, pages={92-94} }